Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines. 2007

Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
Welichem Biotech Incorporated, Technology Place, 316-4475 Wayburne Drive, Burnaby, BC, Canada V5G 3L1.

An efficient synthesis and the cytotoxic activity of a series of substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones 1a-q is described. The synthesis was accomplished in an expedient manner (seven-steps) from commercially available starting materials. Several of the derivatives tested demonstrated significant in vitro cytotoxic activity against the human cancer cell lines H460 (7nM) and LCC6 (> or =28nM). Following SAR and pharmacokinetic studies a derivative was further evaluated for its in vivo anti-tumor activity against a highly angiogenic human melanoma xenograft where it demonstrated significant efficacy as a mono-therapy and in combination with Taxol and Cisplatin.

UI MeSH Term Description Entries
D008297 Male Males
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006574 Heterocyclic Compounds, 2-Ring A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category. Fused Heterocyclic Compounds, Two-Ring,Two Ring Heterocyclic Compounds,2-Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Two Ring,Heterocyclic Compounds, 2 Ring
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
January 2013, Chemical & pharmaceutical bulletin,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
May 1969, The Journal of antibiotics,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
October 1991, Farmaco (Societa chimica italiana : 1989),
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
September 1993, Farmaco (Societa chimica italiana : 1989),
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
August 2005, Biological & pharmaceutical bulletin,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
August 1980, Journal of medicinal chemistry,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
February 1998, Bioorganic & medicinal chemistry,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
March 2012, European journal of drug metabolism and pharmacokinetics,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
March 2006, The Journal of organic chemistry,
Bin Li, and Michael P A Lyle, and Genhui Chen, and Jason Li, and Kaiji Hu, and Liren Tang, and Moulay A Alaoui-Jamali, and John Webster
December 2021, Molecules (Basel, Switzerland),
Copied contents to your clipboard!